Astrana Health, Inc. (ASTH) Stock Price & Analysis
Astrana Health, Inc. (ASTH) rose 1.69% to USD 38.47 as of September 8, 2026 at 05:42 UTC, according to Nexqual real-time market data.
ASTH last closed at USD 37.83; the session ranged USD 37.22–39.24 on volume of 241,953 shares. Market capitalization is $1.91B, with a 52-week range of USD 18.08–51.6 (NCM). Source: Nexqual, September 8, 2026 at 05:42 UTC.
Key Statistics (as of September 8, 2026 at 05:42 UTC)
| Price | USD 38.47 |
|---|---|
| Change | ▲ 1.69% (up) |
| Previous Close | USD 37.83 |
| Open | USD 37.65 |
| Day Range | USD 37.22 – 39.24 |
| 52-Week Range | USD 18.08 – 51.6 |
| Volume | 241,953 shares |
| Market Cap | $1.91B |
| Exchange | NCM |
Technical Analysis (ASTH)
Nexqual's technical model rates ASTH "NEUTRAL" based on 2 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 05:42 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 43.23 (neutral) |
| vs SMA50 | Below (USD 40.86) |
| MACD | -0.29 (negative) |
Analyst Ratings (ASTH)
Wall Street analysts rate ASTH "Strong Buy" based on 8 analysts, with a mean price target of USD 51.5 (range USD 41–65), per Nexqual as of September 8, 2026 at 05:42 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 51.5 |
| High Target | USD 65 |
| Low Target | USD 41 |
| Buy / Hold / Sell | 9 / 1 / 0 |
Earnings (ASTH)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 0.86 |
| Revenue Estimate | $1.02B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.8 vs est 0.73 ▲ beat |
| 2026-03-31 | USD 0.74 vs est 0.65 ▲ beat |
| 2025-12-31 | USD 0.42 vs est 0.33 ▲ beat |
| 2025-09-30 | USD 0.67 vs est 0.61 ▲ beat |
Source: Nexqual, September 8, 2026 at 05:42 UTC.
Financials & Fundamentals (ASTH)
| Total Revenue | $3.84B |
|---|---|
| Revenue Growth (YoY) | +48.50% |
| Gross Margin | +10.46% |
| Operating Margin | +3.53% |
| Profit Margin | +1.05% |
| ROE | +6.90% |
| Debt / Equity | 163.62 |
| Current Ratio | 1.23 |
| Total Cash | $400.79M |
| Total Debt | $979.41M |
| Free Cash Flow | $231.19M |
Source: Nexqual, September 8, 2026 at 05:42 UTC.
Financial Health Score (ASTH)
Nexqual rates Astrana Health, Inc.'s overall financial health "Mixed" across five dimensions, as of September 8, 2026 at 05:42 UTC.
| Growth | Strong — Revenue +56% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 10%, operating 4% |
| Balance Sheet | Weak — $401M cash vs $979M debt |
| Cash Flow | Solid — FCF $231M, 7% margin |
| Efficiency | Mixed — ROE 7%, ROA 3.8% |
Ownership (ASTH)
| Insider Ownership | +22.83% |
|---|---|
| Institutional Ownership | +66.18% |
| Shares Outstanding | 49.60M |
| Float | 38.82M |
| Short % of Float | +12.23% |
Source: Nexqual, September 8, 2026 at 05:42 UTC.
Leadership (ASTH)
Astrana Health, Inc. is led by Brandon K. Sim M.S. (age 31), President & CEO, per Nexqual as of September 8, 2026 at 05:42 UTC.
| President & CEO | Brandon K. Sim M.S. (age 31) |
|---|---|
| Co-Founder & Executive Chairman | Kenneth T. Sim F.A.C.S. (age 71) |
| Co-Founder & Vice Chairman | Thomas S. Lam M.D., M.P.H. (age 76) |
| CFO, COO & Corporate Secretary | Chandan Basho (age 42) |
| Senior Vice President of Health Affairs | WaiChow Young M.D., M.P.H. (age 77) |
Major Backers & Investors (ASTH)
Notable institutional backers of Astrana Health, Inc. include 325 Capital Llc, Wellington Management, Fidelity, according to Nexqual as of September 8, 2026 at 05:42 UTC.
Active Investors
| Investor | Stake |
|---|---|
| 325 Capital Llc | 4.51% |
| Wellington Management | 3.61% |
| Fidelity | 2.53% |
| Bank of America Corporation | 2.38% |
| FMR, LLC | 1.92% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 30.98% |
| Vanguard Group | 22.54% |
| State Street | 4.86% |
| Dimensional Fund Advisors | 4.1% |
| Geode Capital | 3.26% |
Source: Nexqual, September 8, 2026 at 05:42 UTC.
From Astrana Health, Inc.'s Latest SEC 10-K Filing (filed 2026-03-12)
Key Strengths & Strategy (as disclosed to the SEC)
- Astrana Health, Inc., a healthcare management company, provides medical care services in the United States.
- The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
- The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
- Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARDT | Ardent Health, Inc. | USD 10.91 | ▲ 0% |
| BWIN | The Baldwin Insurance Group, In | USD 30.88 | ▼ 0.42% |
| PRVA | Privia Health Group, Inc. | USD 20.66 | ▼ 0.29% |
| ALHC | Alignment Healthcare, Inc. | USD 13.54 | ▼ 0.37% |
| BTSG | BrightSpring Health Services, I | USD 60.73 | ▲ 0.8% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:42 UTC. This page is informational and not investment advice.